POINT Biopharma Global Inc. (PNT) Reports Q3 Loss of $0.86/sh

POINT Biopharma Global Inc. (NASDAQ: PNT) reported Q3 EPS of ($0.86), versus ($0.75) reported last year. Revenue for the quarter came in at $869.7 thousand, versus $159.5 thousand reported last year.

For earnings history and earnings-related data on POINT Biopharma Global Inc. (PNT) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• California Resources completes $63M acquisition of Crimson Midstream
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue